<DOC>
	<DOCNO>NCT01549704</DOCNO>
	<brief_summary>The purpose study determine whether Adductor-Canal-Blockade ( ACB ) superior placebo come analgetic efficacy high pain responder Total Knee Arthroplasty ( TKA ) . High pain responder define patient report VAS &gt; 60 knee flexion 1. 2. day surgery .</brief_summary>
	<brief_title>Effect Adductor-Canal-Blockade High Pain Responders After Total Knee Arthroplasty</brief_title>
	<detailed_description>The patient include 1. 2. day surgery . All TKA patient screen . Those report VAS &gt; 60 active 45 degree knee flexion ask participate . Included patient receive 2xACB ( singleshot ) first placebo ( 30ml saline ) ropivacaine ( 30ml ropivacaine 7,5mg/ml ) way around ( randomize ) . There 45 minute two blockade . The blockade ultrasound guide .</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>TKA within 48 hour VAS &gt; 60 active 45 degree knee flexion despite conventional pain medication . Informed consent ASA 13 BMI 1840 Unable communicate Danish Allergic reaction toward drug use Abuse alcohol/drugs Unable cooperate</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Adductor canal blockade ( ACB )</keyword>
	<keyword>High pain responder</keyword>
	<keyword>US-guided nerve block</keyword>
</DOC>